ChronicDX® is building intelligent, systems-based management of long-term health conditions for underserved populations across the world — connecting the dots that today's siloed healthcare systems cannot.
Across the world, hundreds of millions of people live with multiple long-term health conditions managed by disconnected specialists, siloed systems, and reactive protocols that address symptoms rather than root causes. ChronicDX® exists to change that.
We believe that intelligent, connected health management — built on real-world data, accessible offline, and designed for equity — can transform outcomes for populations that today's health systems leave behind.
— ChronicDX® Mission StatementCurrent care protocols address individual symptoms in isolation, missing the interconnected nature of chronic conditions and the systemic factors that drive them.
A patient with diabetes, hypertension and depression may see three specialists who never communicate. ChronicDX® maps the connections between conditions that clinicians cannot see.
The burden of chronic disease is heaviest in low- and middle-income countries, where health system infrastructure is least equipped to manage it. Existing digital health tools were not built for these settings.
Our platform is grounded in health equity, built for real-world conditions, and designed to complement — not replace — the clinical relationships at the centre of good care.
We map the interactions between conditions — not individual diagnoses in isolation. Our clinical decision support tools help identify root-cause patterns that siloed care misses, with all recommendations reviewed and validated by qualified healthcare professionals.
Root-Cause AnalyticsBuilt for communities where connectivity is intermittent. ChronicDX® functions fully offline and synchronises when connectivity is available, with no data loss.
Low-Bandwidth ReadyOur platform is designed to extend the reach of clinical teams by empowering community health workers with guided protocols, translated into local languages.
Last-Mile DeliveryUnder the Wellness Connections brand, we use person-centred language — "long-term health conditions" rather than "chronic disease" — designed for communities where stigma is a real barrier.
Health Equity by DesignOur clinical decision support tools are built on explainable, interpretable methods — not black-box predictions. Every recommendation is traceable, auditable, and clinician-reviewable. All patient data is encrypted, stored securely, and protected under healthcare privacy regulations including HIPAA and GDPR where applicable.
Transparent & SecureChronicDX® is grounded in a nine-community global focus group programme spanning five regions, ensuring the platform is built on lived experience, not assumptions.
Community-Led DesignChronicDX® provides clinical decision support and care navigation tools that assist healthcare professionals and patients. The platform delivers actionable insights for payers and health systems seeking to improve outcomes and reduce costs, while offering researchers and public health organizations comprehensive data analytics for population health management. We believe in transparency about the role and limits of technology in healthcare.
Streamlined care coordination, evidence-based decision support, and comprehensive patient insights across multiple chronic conditions — helping clinicians deliver better outcomes with greater efficiency.
Personalized health tracking, medication management, and seamless communication with care teams — empowering individuals to actively manage their long-term health conditions with confidence.
Reduced hospital readmissions, optimized resource allocation, and improved population health metrics — delivering measurable ROI through better chronic disease management and preventive care.
Guided clinical protocols, multilingual support, and offline-first functionality — extending quality care to underserved communities with limited connectivity and healthcare infrastructure.
De-identified aggregate data, population health analytics, and real-world evidence generation — advancing understanding of chronic disease patterns and intervention effectiveness across diverse populations.
Improved employee health outcomes, reduced absenteeism, and lower healthcare costs — supporting workforce wellbeing while managing the financial impact of chronic conditions.
Our clinical decision support tools are built on explainable, interpretable methods — not black-box algorithms. Every recommendation can be traced back to its evidence base, clinical guidelines, and patient data inputs. Healthcare providers can review the reasoning behind each suggestion and override or modify recommendations based on their clinical expertise and knowledge of individual patient circumstances.
ChronicDX® is designed to augment clinical expertise, not replace it. Our platform extends the reach of healthcare teams by providing data-driven insights while preserving the irreplaceable role of human judgment, empathy, and the provider-patient relationship.
Our initial markets span five regions — from North America and the Caribbean to South America, Sub-Saharan Africa, and Asia-Pacific — selected for their diversity of health system contexts, community need, and strategic partnership opportunity.
Home base and innovation hub. The US market provides access to leading clinical research networks, development finance institutions, and the academic partnerships that anchor ChronicDX®'s evidence base.
A priority region with high burdens of non-communicable diseases — particularly diabetes, hypertension and obesity — across island communities with limited specialist access and fragmented health infrastructure.
A region of immense health system diversity and rapidly growing chronic disease burden. From Brazil's expansive community health worker programme to Colombia's innovation in primary care, South America offers significant partnership and scale opportunities for ChronicDX®.
A leading digital health market in Africa with a large community health worker network and growing burden of chronic conditions. Kenya's health tech ecosystem is among the most active on the continent.
A middle-income country with strong government health investment and an established primary care infrastructure. Botswana's scale and political stability make it an ideal research and pilot environment.
A country with one of West Africa's most developed public health systems and a growing digital health policy agenda. Ghana's National Health Insurance Scheme creates a natural integration pathway for ChronicDX®.
Led by our Asia-Pacific Clinical Adviser, this region spans diverse health system contexts — from high-income markets in Australia and Singapore to rapidly developing systems across Southeast Asia and the Pacific Islands.
In many communities, language around "chronic" illness carries stigma that prevents people from seeking care. Wellness Connections is our patient-facing mobile and web application — warm, empowering, and forward-looking. The app is downloadable on smartphones, tablets, and accessible via web browsers.
Wellness Connections includes integrated modules for:
Behind it, ChronicDX® powers the intelligence: clinical decision support tools, condition-interconnection mapping, clinical analytics, and systems-based insights that support healthcare professionals in delivering better outcomes. All clinical recommendations require validation by qualified healthcare providers.
ChronicDX® was founded by a team spanning academic medicine, global health technology, and international development finance — united by a conviction that the chronic disease crisis in lower-income countries demands a fundamentally different kind of tool.
Our founding team brings together clinical medicine, with deep experience in cardiology and multi-morbidity; health technology and clinical decision support, with expertise in offline-first platform development; equitable access, grounded in community health design and health equity practice; and sustainable financing, and partnerships spanning academia, investors, philanthropy and nongovernmental organizations, including in Oxford, Geneva and Washington, DC.
We are currently conducting a global focus group programme — listening as we build — to ensure ChronicDX® is grounded in the real experiences of the communities it will serve. We are also:
Former World Bank Director, ICRC Special Envoy, and current Boards chair with 15+ years in global health technology, development finance, and health equity. Oxford Saïd Business School Executive MBA candidate (Director's Award Scholarship). Based in Washington DC, Oxford, and Geneva.
US Board-Certified Anesthesiologist and Pain Management Specialist with deep clinical expertise in chronic disease management, quality assurance, and public health education.
30+ years in health technology, 700+ products delivered. Former CEO of ShareMy.Health, CTO of Lumeris. 2014 CEO of the Year. Expert in platform architecture, clinical decision support systems, and offline-first infrastructure for low-resource settings.
Director of the Victorian Heart Institute, Monash University. Co-lead of the Lancet Commission on Cardiovascular Disease in the Asia-Pacific Region. Oxford Executive MBA Candidate. Leading ChronicDX® introduction into Asia-Pacific health system networks.
ChronicDX® is actively seeking partnerships across clinical institutions, academic organisations, community health networks, and development finance. If your work touches any of these areas, we would like to hear from you.
Hospitals, primary care networks, and health ministries in our target markets seeking to extend the reach and intelligence of their chronic disease programmes.
Universities, research institutes, and public health schools seeking to embed evidence-based research into the design and evaluation of health technology at scale.
Impact investors, philanthropies, and global health funders working to close the chronic disease management gap in lower-income settings.
We are launching our community focus group programme across our seven target markets — the United States, Caribbean, Kenya, Botswana, Ghana, Asia-Pacific and South America — listening to patients, community health workers, clinicians, and administrators. If your organisation works with any of these communities, we welcome a conversation about participation.
ChronicDX® is building intelligent, systems-based management of long-term health conditions designed specifically to fill gaps in developed and emerging markets.
TAM (Total Addressable Market)
$240B+
Globally
SAM (Serviceable Available Market)
$28B
2026-2031 Target Markets
SOM (Serviceable Obtainable Market)
$420M
Year 5 Target
Preliminary Data. Subject to further verification.
Founder & CEO
Former World Bank Director, ICRC Special Envoy, and current Boards chair. 15+ years in global health technology and development finance. Oxford Saïd Business School Executive MBA candidate (Director's Award Scholarship).
Chief Medical Officer
US Board-Certified Anesthesiologist and Pain Management Specialist with deep expertise in chronic disease management and public health education.
Chief Technology Officer
30+ years in health technology, 700+ products delivered. Former CEO of ShareMy.Health, CTO of Lumeris. 2014 CEO of the Year.
Strategic Adviser
Director of the Victorian Heart Institute, Monash University. Co-lead of the Lancet Commission on Cardiovascular Disease in the Asia-Pacific Region. Oxford Executive MBA Candidate.
Single-Condition Apps
Diabetes, hypertension, and obesity management tools exist in isolation. Real patients have multiple interconnected conditions that affect each other daily.
Enterprise EMRs
Built for billing and compliance, not patient empowerment. Require expensive infrastructure and constant internet connectivity.
Emerging Market Platforms
Focus on acute care or single-disease verticals. Miss the systems-level complexity of chronic multi-morbidity.
For detailed information on our investment opportunity, market analysis, and financial projections:
Colin Bruce, PhD
Founding CEO
[email protected]
Washington DC | Oxford | Geneva
Based on your experience, or that of family members, we would welcome your feedback via the questionnaires linked below. Completing each will take about 15 minutes, and your responses will be confidential and anonymous.
Whether you are a patient advocate, clinician, health system, researcher, investor, or potential partner — we want to hear from you.
ChronicDX® is committed to protecting your privacy and handling your personal health information with the highest standards of security and transparency.
Personal Information: Name, email address, phone number, date of birth, and location data (for service delivery and care coordination).
Health Information: Medical history, current health conditions, medications, symptoms, vital signs (blood pressure, glucose levels, etc.), laboratory results, and provider notes. This information is classified as Protected Health Information (PHI) under HIPAA.
Usage Data: App interaction data, login times, feature usage patterns, and device information (for platform optimization and technical support).
Communication Data: Messages exchanged with healthcare providers, support tickets, and feedback submissions.
For users in the United States: We process your health information under HIPAA's Treatment, Payment, and Healthcare Operations provisions. Your explicit written consent authorizes data collection and use as described in our HIPAA Authorization and Notice of Privacy Practices.
For users in the European Union, United Kingdom, and other GDPR jurisdictions: We process your data based on: (1) your explicit consent for healthcare services, (2) contractual necessity to deliver our platform, (3) legitimate interests in improving healthcare delivery, and (4) compliance with legal obligations.
You may withdraw consent at any time by contacting us at [email protected]. Withdrawal does not affect the lawfulness of processing before withdrawal.
Encryption: All data is encrypted in transit (using TLS 1.3) and at rest (using AES-256 encryption). Access to health information requires multi-factor authentication.
Infrastructure: Data is stored on HIPAA-compliant, SOC 2 Type II certified cloud infrastructure with regular security audits and penetration testing.
Access Controls: Role-based access ensures only authorized healthcare team members can view patient information. All access is logged and auditable.
Retention Period: Active health records are retained for the duration of your use of our services plus 7 years as required by medical record retention laws. De-identified research data may be retained indefinitely. Upon request, we will delete your data subject to legal retention requirements.
We work with carefully vetted third-party service providers who are bound by Business Associate Agreements (BAAs) under HIPAA and Data Processing Agreements (DPAs) under GDPR. These include:
We never sell your personal health information. We do not share identifiable health data with third parties for marketing purposes.
Data may be shared with your explicit consent, to comply with legal obligations (court orders, regulatory requests), or in de-identified, aggregated form for research purposes.
Under HIPAA (US users) and GDPR (EU/UK users), you have the following rights:
Our website and app use cookies and similar technologies for:
Essential Cookies: Required for platform functionality (authentication, security, session management)
Analytics Cookies: Help us understand usage patterns and improve the platform (opt-out available)
Performance Cookies: Monitor system performance and identify technical issues
You can manage cookie preferences through your browser settings. Disabling essential cookies may limit platform functionality.
To exercise your privacy rights, request access to your data, or ask questions about our privacy practices:
Email: [email protected]
Mail: ChronicDX® Inc., Data Privacy Office, [Address to be updated upon incorporation]
Response Time: We respond to privacy requests within 30 days as required by law.
This Privacy & Data Protection statement was last updated: April 2026. We will notify users of material changes via email and in-app notification.
For complete details, please review our full legal documentation (available upon platform launch):